JPWO2022107789A1 - - Google Patents

Info

Publication number
JPWO2022107789A1
JPWO2022107789A1 JP2022514472A JP2022514472A JPWO2022107789A1 JP WO2022107789 A1 JPWO2022107789 A1 JP WO2022107789A1 JP 2022514472 A JP2022514472 A JP 2022514472A JP 2022514472 A JP2022514472 A JP 2022514472A JP WO2022107789 A1 JPWO2022107789 A1 JP WO2022107789A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022514472A
Other versions
JPWO2022107789A5 (ja
JP7089131B1 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022107789A1 publication Critical patent/JPWO2022107789A1/ja
Priority to JP2022093700A priority Critical patent/JP2022120088A/ja
Application granted granted Critical
Publication of JP7089131B1 publication Critical patent/JP7089131B1/ja
Publication of JPWO2022107789A5 publication Critical patent/JPWO2022107789A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022514472A 2020-11-18 2021-11-17 塩化ポリドロニウムを含有する水性点眼液 Active JP7089131B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022093700A JP2022120088A (ja) 2020-11-18 2022-06-09 塩化ポリドロニウムを含有する水性点眼液

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020191942 2020-11-18
JP2020191942 2020-11-18
PCT/JP2021/042165 WO2022107789A1 (ja) 2020-11-18 2021-11-17 塩化ポリドロニウムを含有する水性点眼液

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022093700A Division JP2022120088A (ja) 2020-11-18 2022-06-09 塩化ポリドロニウムを含有する水性点眼液

Publications (3)

Publication Number Publication Date
JPWO2022107789A1 true JPWO2022107789A1 (ja) 2022-05-27
JP7089131B1 JP7089131B1 (ja) 2022-06-21
JPWO2022107789A5 JPWO2022107789A5 (ja) 2022-11-24

Family

ID=81709053

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022514472A Active JP7089131B1 (ja) 2020-11-18 2021-11-17 塩化ポリドロニウムを含有する水性点眼液
JP2022093700A Pending JP2022120088A (ja) 2020-11-18 2022-06-09 塩化ポリドロニウムを含有する水性点眼液

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022093700A Pending JP2022120088A (ja) 2020-11-18 2022-06-09 塩化ポリドロニウムを含有する水性点眼液

Country Status (2)

Country Link
JP (2) JP7089131B1 (ja)
WO (1) WO2022107789A1 (ja)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107837276A (zh) * 2016-09-19 2018-03-27 刘力 局部给药的药物组合物
CN112933075A (zh) * 2019-12-11 2021-06-11 刘力 局部给药的葛根相关药物组合物

Also Published As

Publication number Publication date
WO2022107789A1 (ja) 2022-05-27
JP2022120088A (ja) 2022-08-17
JP7089131B1 (ja) 2022-06-21

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022024743A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR112022009896A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011610A2 (ja)
BR112023011539A2 (ja)
BR112023008976A2 (ja)
JPWO2022107791A1 (ja)
JPWO2022107789A1 (ja)
JPWO2022107790A1 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220303

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220303

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220428

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220531

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220609

R150 Certificate of patent or registration of utility model

Ref document number: 7089131

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150